Healthy Skepticism Library item: 15383
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Nathan VL.
UPDATE 1-Par Pharma gets subpoena on unit's promotional practice
Reuters 2009 Mar 27
http://www.reuters.com/article/rbssHealthcareNews/idUSBNG39708120090327
Full text:
- Says DoJ probing promotional practices for Megace
- Says company intends to cooperate with DoJ Par Pharmaceutical Cos Inc (PRX.N) said the United States Department of Justice is currently investigating promotional practices of its unit in the sales of its appetite-stimulant Megace.
In a regulatory filing, the company said it received a subpoena from the department, requesting documents related to Megace, and it intended to fully cooperate with the inquiry.
Megace is a brand name product of Strativa Pharmaceuticals, a division of its unit.
Shares of the Woodcliff Lake, New Jersey-based company closed down 12 percent at $9.85 Friday on the New York Stock Exchange.
